HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$2.36
Day range
$2.27 - $2.50
Year range
$2.27 - $8.40
Market cap
74.41M USD
Avg Volume
153.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.19M | 14.18% |
Net income | -2.18M | 65.15% |
Net profit margin | — | — |
Earnings per share | -0.07 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 403.00K | -87.69% |
Total assets | 491.19K | -85.98% |
Total liabilities | 652.29K | 34.06% |
Total equity | -161.11K | — |
Shares outstanding | 29.76M | — |
Price to book | -236.00 | — |
Return on assets | -602.63% | — |
Return on capital | -1,635.62% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.18M | 65.15% |
Cash from operations | -863.13K | 55.50% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -863.13K | -126.37% |
Free cash flow | -50.67K | -112.48% |
About
Founded
2021
Headquarters
Website
Employees
5
